212 related articles for article (PubMed ID: 9349482)
1. Human papillomavirus type 16 E7 binds to the conserved carboxy-terminal region of the TATA box binding protein and this contributes to E7 transforming activity.
Massimi P; Pim D; Banks L
J Gen Virol; 1997 Oct; 78 ( Pt 10)():2607-13. PubMed ID: 9349482
[TBL] [Abstract][Full Text] [Related]
2. Binding of the human papillomavirus type 16 E7 oncoprotein and the adeno-associated virus Rep78 major regulatory protein in vitro and in yeast and the potential for downstream effects.
Hermonat PL; Santin AD; Zhan D
J Hum Virol; 2000; 3(3):113-24. PubMed ID: 10881991
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the interaction between human papillomavirus type 16 E7 and the TATA-binding protein, TBP.
Phillips AC; Vousden KH
J Gen Virol; 1997 Apr; 78 ( Pt 4)():905-9. PubMed ID: 9129664
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus-16 E7 protein inhibits the DNA interaction of the TATA binding transcription factor.
Maldonado E; Cabrejos ME; Banks L; Allende JE
J Cell Biochem; 2002; 85(4):663-9. PubMed ID: 11968006
[TBL] [Abstract][Full Text] [Related]
5. HPV-16 E7 and adenovirus E1a complex formation with TATA box binding protein is enhanced by casein kinase II phosphorylation.
Massimi P; Pim D; Storey A; Banks L
Oncogene; 1996 Jun; 12(11):2325-30. PubMed ID: 8649772
[TBL] [Abstract][Full Text] [Related]
6. Repression of p53 transcriptional activity by the HPV E7 proteins.
Massimi P; Banks L
Virology; 1997 Jan; 227(1):255-9. PubMed ID: 9007083
[TBL] [Abstract][Full Text] [Related]
7. Regulation of human papillomavirus type 16 E7 activity through direct protein interaction with the E2 transcriptional activator.
Gammoh N; Grm HS; Massimi P; Banks L
J Virol; 2006 Feb; 80(4):1787-97. PubMed ID: 16439535
[TBL] [Abstract][Full Text] [Related]
8. Specific in vitro interaction between papillomavirus E2 proteins and TBP-associated factors.
Carrillo E; Garrido E; Gariglio P
Intervirology; 2004; 47(6):342-9. PubMed ID: 15564746
[TBL] [Abstract][Full Text] [Related]
9. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
[TBL] [Abstract][Full Text] [Related]
10. p53 and SV40 T antigen bind to the same region overlapping the conserved domain of the TATA-binding protein.
Martin DW; Subler MA; Muñoz RM; Brown DR; Deb SP; Deb S
Biochem Biophys Res Commun; 1993 Aug; 195(1):428-34. PubMed ID: 8395834
[TBL] [Abstract][Full Text] [Related]
11. Interaction of the HPV E7 proteins with the pCAF acetyltransferase.
Avvakumov N; Torchia J; Mymryk JS
Oncogene; 2003 Jun; 22(25):3833-41. PubMed ID: 12813456
[TBL] [Abstract][Full Text] [Related]
12. Interaction of human papillomavirus 8 regulatory proteins E2, E6 and E7 with components of the TFIID complex.
Enzenauer C; Mengus G; Lavigne A; Davidson I; Pfister H; May M
Intervirology; 1998; 41(2-3):80-90. PubMed ID: 9820841
[TBL] [Abstract][Full Text] [Related]
13. The HPV-16 E7 oncoprotein binds Skip and suppresses its transcriptional activity.
Prathapam T; Kühne C; Banks L
Oncogene; 2001 Nov; 20(52):7677-85. PubMed ID: 11753645
[TBL] [Abstract][Full Text] [Related]
14. The viral oncoproteins Ad5 E1A, HPV16 E7 and SV40 TAg bind a common region of the TBP-associated factor-110.
Mazzarelli JM; Atkins GB; Geisberg JV; Ricciardi RP
Oncogene; 1995 Nov; 11(9):1859-64. PubMed ID: 7478615
[TBL] [Abstract][Full Text] [Related]
15. Different arrangement of human papillomavirus E2 binding sites distinguishes cutaneous types from those associated with mucosal lesions.
Garrido-Guerrero E; Carrillo E; Guido M; Zamorano R; García-Carranca A; Gariglio P
Arch Med Res; 1996; 27(3):389-94. PubMed ID: 8854400
[TBL] [Abstract][Full Text] [Related]
16. Adeno-associated virus major Rep78 protein disrupts binding of TATA-binding protein to the p97 promoter of human papillomavirus type 16.
Su PF; Chiang SY; Wu CW; Wu FY
J Virol; 2000 Mar; 74(5):2459-65. PubMed ID: 10666281
[TBL] [Abstract][Full Text] [Related]
17. Mutational analysis of HPV-18 E6 identifies domains required for p53 degradation in vitro, abolition of p53 transactivation in vivo and immortalisation of primary BMK cells.
Pim D; Storey A; Thomas M; Massimi P; Banks L
Oncogene; 1994 Jul; 9(7):1869-76. PubMed ID: 8208532
[TBL] [Abstract][Full Text] [Related]
18. Interaction of the fork head domain transcription factor MPP2 with the human papilloma virus 16 E7 protein: enhancement of transformation and transactivation.
Lüscher-Firzlaff JM; Westendorf JM; Zwicker J; Burkhardt H; Henriksson M; Müller R; Pirollet F; Lüscher B
Oncogene; 1999 Oct; 18(41):5620-30. PubMed ID: 10523841
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of transformation by the human papillomaviruses.
Howley PM; Münger K; Werness BA; Phelps WC; Schlegel R
Princess Takamatsu Symp; 1989; 20():199-206. PubMed ID: 2562182
[TBL] [Abstract][Full Text] [Related]
20. The Mus musculus Papillomavirus Type 1 E7 Protein Binds to the Retinoblastoma Tumor Suppressor: Implications for Viral Pathogenesis.
Wei T; Grace M; Uberoi A; Romero-Masters JC; Lee D; Lambert PF; Munger K
mBio; 2021 Aug; 12(4):e0227721. PubMed ID: 34465025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
